Hermetica Superfood Encyclopedia
The Short Answer
UDP-Glucuronosyltransferase is a vital liver enzyme that helps your body detoxify drugs, hormones, and toxins. People take it primarily to enhance whole-body detoxification and support liver health.
CategoryEnzyme
GroupEnzyme
Evidence LevelPreliminary
Primary Keywordudp-glucuronosyltransferase benefits
Synergy Pairings4
UDP-Glucuronosyltransferase — botanical close-up
Health Benefits
Supports detoxification by aiding in the excretion of drugs, toxins, and environmental pollutants through glucuronidation, a key liver process. - Contributes to hormone regulation by metabolizing and eliminating excess estrogens and steroid hormones, helping maintain hormonal balance. - Enhances liver health by facilitating the removal of bilirubin and other metabolic waste, reducing the risk of jaundice and liver overload. - Promotes antioxidant defense by neutralizing reactive metabolites, thereby protecting cells from oxidative stress. - May reduce the risk of certain cancers by accelerating the clearance of carcinogens, as shown in studies where increased UDP-glucuronosyltransferase activity correlated with up to 30% lower cancer risk. - Supports medication metabolism by breaking down pharmaceuticals efficiently, potentially reducing drug side effects and interactions. - Improves immune resilience by helping the body process and eliminate bacterial endotoxins, supporting overall immune function. - Assists in the management of metabolic syndrome by aiding in the detoxification of lipid peroxidation products, contributing to better metabolic health.
Origin & History
Natural habitat
UDP-Glucuronosyltransferase is an enzyme found in the liver, responsible for the glucuronidation of various substances, aiding in their excretion. It is naturally produced in the body and plays a critical role in detoxification.
“UDP-Glucuronosyltransferase has been studied since the mid-20th century for its role in detoxification and drug metabolism.”Traditional Medicine
Scientific Research
Research includes genetic studies and clinical trials examining its role in drug metabolism and detoxification processes.
Preparation & Dosage
Traditional preparation
No direct supplementation available; focus on supporting liver health. Consult a healthcare provider before use.
Nutritional Profile
- Part of the phase II detoxification pathway. - Requires UDP-glucuronic acid as a substrate. - Genetic variations can influence enzyme activity.
How It Works
Mechanism of Action
UDP-glucuronosyltransferase (UGT) is an endogenous Phase II detoxification enzyme that catalyzes glucuronidation—the conjugation of glucuronic acid to lipophilic substrates including drugs, xenobiotics, bilirubin, hormones, and environmental toxins. This process increases water solubility and facilitates biliary and urinary excretion. UGT exists in multiple isoforms (UGT1A, UGT2B families) with tissue-specific expression patterns, primarily in the liver but also in intestines, kidneys, and brain.
Clinical Evidence
Enhanced UGT activity supports hepatic detoxification capacity, hormone metabolism (including estrogen clearance), and bilirubin elimination. Genetic polymorphisms (e.g., UGT1A1) affect individual detoxification efficiency and drug metabolism rates. Supplementation does not directly increase UGT enzyme; support focuses on substrates and cofactors (NAD+, B vitamins) that optimize existing enzyme function. Clinical relevance includes personalized medicine for drug dosing and detoxification support in individuals with compromised Phase II capacity.
Safety & Interactions
UGT is a natural endogenous enzyme with no direct toxicity. Genetic variants may impair function, increasing sensitivity to certain drugs and toxins. Compounds like silymarin, milk thistle, and cruciferous vegetable extracts may modestly support UGT expression. No direct supplementation of UGT protein is available or necessary; safety concerns relate to enzyme inhibitors (certain flavonoids at high doses, NSAIDs) rather than activation. Clinical monitoring is recommended for individuals with identified UGT polymorphisms.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
UGTUDPGTGlucuronosyltransferaseUDP-GTUridine 5'-diphospho-glucuronosyltransferaseGlucuronyl transferasePhase II detoxification enzymeBilirubin UDP-glucuronosyltransferaseUGT1A1UGT2BMicrosomal UDP-glucuronosyltransferase
Frequently Asked Questions
What is UDP-Glucuronosyltransferase and how does it work in the body?
UDP-Glucuronosyltransferase (UGT) is a liver enzyme that facilitates glucuronidation, a Phase II detoxification process where glucuronic acid is conjugated to toxins, drugs, and hormones to make them water-soluble for excretion. This enzyme transfers glucuronic acid from UDP-glucuronic acid to target molecules, enabling their elimination through urine or bile.
Which medications can affect UDP-Glucuronosyltransferase activity?
Certain medications can either inhibit or induce UGT activity, including fluconazole and valproic acid (inhibitors), while rifampin and phenobarbital act as inducers. These interactions can significantly affect the metabolism and clearance rates of other drugs, hormones, and toxins processed through the glucuronidation pathway.
Can genetic variations in UDP-Glucuronosyltransferase affect detoxification?
Yes, genetic polymorphisms in UGT genes, particularly UGT1A1, UGT2B7, and UGT2B15, can result in reduced enzyme activity ranging from 10-90% of normal function. These variations, such as Gilbert's syndrome caused by UGT1A1*28 polymorphism, can impair bilirubin clearance and affect drug metabolism efficiency.
How does UDP-Glucuronosyltransferase help with hormone metabolism?
UGT enzymes, specifically UGT1A1 and UGT2B family members, metabolize estrogens, testosterone, and other steroid hormones by adding glucuronic acid groups to make them inactive and water-soluble. This process is crucial for maintaining hormonal balance and preventing hormone accumulation that could lead to estrogen dominance or other hormonal disorders.
What foods or supplements can support UDP-Glucuronosyltransferase function?
Cruciferous vegetables like broccoli and Brussels sprouts contain compounds that can upregulate UGT expression, while supplements like calcium D-glucarate (500-1000mg daily) may support glucuronidation by inhibiting beta-glucuronidase enzymes. Green tea catechins and curcumin have also been shown to modulate UGT activity in clinical studies.
Can UDP-Glucuronosyltransferase activity be impaired by alcohol consumption or liver disease?
Yes, chronic alcohol use can significantly reduce UDP-Glucuronosyltransferase activity by damaging liver tissue and depleting cofactors needed for the enzyme to function properly. Liver diseases such as cirrhosis, hepatitis, and fatty liver disease also impair UGT enzyme expression and activity, reducing the body's ability to detoxify drugs and hormones. This impairment can lead to accumulation of toxic metabolites and increased risk of adverse drug effects.
What is the difference between Phase II conjugation and other liver detoxification pathways?
UDP-Glucuronosyltransferase is a Phase II enzyme that works in conjugation, making toxins and drugs water-soluble for easier excretion in urine and bile—this differs from Phase I enzymes (like cytochrome P450) that break down compounds into intermediate metabolites first. While Phase I creates metabolites that may be reactive, Phase II conjugation through glucuronidation directly neutralizes and prepares substances for elimination. Phase III transporters then move these conjugated metabolites out of liver cells for final excretion.
Why do certain individuals experience slower drug metabolism or increased medication side effects related to UDP-Glucuronosyltransferase?
Some people carry genetic polymorphisms in UGT genes (such as UGT1A1, UGT2B7) that reduce enzyme expression or activity, making them 'poor metabolizers' of certain drugs and xenobiotics. Additionally, age, sex hormones, disease state, and concurrent medications can suppress UGT enzyme activity, causing drugs to accumulate to higher-than-expected levels. Individuals with these genetic variations or circumstances may require dose adjustments or alternative medications to avoid toxicity.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w udp-glucuronosyltransferase curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
